Showing results (141-150 of 191) with videos related to

Sort By:
Pageof 20
Science (New York, N.Y.)|February 24, 1995
Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell lineS P Lees-Miller, R Godbout, D W Chan, et al.
The New England Journal of Medicine|May 21, 1992
Hepatitis B and hepatitis C in emergency department patientsG D Kelen, G B Green, R H Purcell, et al.
The Journal of Urology|July 29, 1998
Influence of radical prostatectomy on serum hormone levelsL R Miller, A W Partin, D W Chan, et al.
Urology|February 1, 1997
Prostate-specific antigen in men born with bladder exstrophyR I Silver, A W Partin, J I Epstein, et al.
Annals of Emergency Medicine|September 1, 1991
The potential utility of a rapid CK-MB assay in evaluating emergency department patients with possible myocardial infarctionG B Green, K N Hansen, D W Chan, et al.
Urology|August 12, 1999
Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative modelW J Catalona, A W Partin, J A Finlay, et al.
Urology|December 1, 1996
Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancerJ D Pearson, A A Luderer, E J Metter, et al.
Urology|June 7, 2000
Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assaysR L Vessella, P H Lange, A W Partin, et al.
The Prostate|July 1, 1995
Longitudinal evaluation of serum androgen levels in men with and without prostate cancerH B Carter, J D Pearson, E J Metter, et al.
The Journal of Urology|November 17, 1998
Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findingsJ I Epstein, D W Chan, L J Sokoll, et al.
Pageof 20